[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XX% -XX%
6 Months: XX% +28%
1 Year: XX% +28%
1-Year High: XXX% on 2024-11-15
1-Year Low: XX% on 2025-03-26
Most Supportive Themes
- Board Appointments: (20%) Rani Therapeutics announced the appointment of Abe Bassan and Vasudev Bailey Ph.D. to its Board of Directors, representing new investors Samsara & Anomaly.
- Robotic Pill Technology: (30%) Rani Therapeutics' robotic pill technology is being highlighted as a potential game-changer for subcutaneous injection treatments, aiming to replace traditional needles.
- Semaglutide Preclinical Data: (25%) The company is set to present preclinical data on the oral delivery of semaglutide using the RaniPill Capsule at ObesityWeek 2025.
Most Critical Themes
- Insider Trading Alert: (15%) A significant purchase of shares by a Director and XX% Owner, Imran Mir A, indicates strong insider confidence in Rani Therapeutics.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | X | X% | XX | X% | ||
| YouTube | X | X% | ||||
| Total | XX | X% | X | X% | X | NaN% |